Covidien Financial Statements
Covidien Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | September |
© 2009 Morningstar, Inc. Financial Data provided by
Covidien Income Statement
| 2008 | 2007 | 2006 | |
|---|---|---|---|
| Revenue ($ mil.) | 9,910.0 | 10,170.0 | 9,647.0 |
| Gross Profit ($ mil.) | 5,309.0 | 4,837.0 | 4,486.0 |
| Operating Income ($ mil.) | 2,188.0 | 339.0 | 2,006.0 |
| Total Net Income ($ mil.) | 1,361.0 | (342.0) | 1,155.0 |
| Diluted EPS (Net Income) | 2.70 | (0.69) | -- |
Covidien Stock Quote & Chart
11/06/09 16:00:23 EST •
NYSE •
44.05
•
 0.0000
•
0.0000 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Covidien Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 2.18 | 2.38 | 7.01 |
| Price/Earnings Ratio | 18.05 | 27.93 | 25.51 |
| Price/Book Ratio | 2.72 | 2.79 | 6.74 |
| Price/Cash Flow Ratio | 12.95 | 12.82 | 43.48 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Covidien Financial Ratios
Covidien Competitive Intelligence
| Becton, Dickinson | Bard | Johnson & Johnson | |
|---|---|---|---|
| Annual Sales ($ mil.) | 7,155.9 | 2,452.1 | 63,747.0 |
| Employees | 28,300 | 11,000 | 118,700 |
| Market Cap ($ mil.) | 16,886.6 | 7,567.5 | 166,373.7 |
Competitive Landscape
